Breaking Research News from Breastcancer.org
Comments
-
Breast Cancer Treatment Linked to Increased Risk of Diabetes and High Blood Pressure
May 25, 2022
Women with a history of invasive breast cancer had a higher risk of developing high blood pressure and diabetes than women without a history of breast cancer. Read more... -
A New Standard of Care? Enhertu Improves Survival in People With Metastatic HER2-Low Breast Cancer
June 6, 2022
Compared with doctors' choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer. Read more... -
Lying Facedown for Radiation Therapy Causes Fewer Skin Side Effects in Women With Large Breasts
June 2, 2022
During external whole-breast radiation therapy for breast cancer, women with large breasts who lay facedown had fewer skin side effects than women who lay faceup. Read more... -
Many Black Metastatic Breast Cancer Patients Never Informed About Clinical Trials
June 8, 2022
Many Black people diagnosed with metastatic breast cancer never find out about clinical trials from their doctors even though most of them are open to participating in one. Read more... -
Trodelvy Slightly Improves Progression-Free Survival for Pre-treated Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer
June 8, 2022
Trodelvy (chemical name: sacituzumab govitecan-hziy) slightly improved progression-free survival in people diagnosed with metastatic hormone receptor-positive, HER2-negative breast cancer previously treated with hormonal therapy, a CDK4/6 inhibitor, and multiple lines of chemotherapy. Read more... -
Well this is really discouraging news. Medical racism is real. All women get breast cancer. I hope this study helps to promote change in the process to promote more inclusiveness. Thanks for posting this study.
-
Thanks marigold -- we agree. We hope this incites change also!
-
Some Older Women With Luminal A Breast Cancer May Be Able To Skip Radiation After Lumpectomy
June 15, 2022
Women ages 55 and older diagnosed with early-stage, estrogen receptor-positive, progesterone receptor-positive, HER2-negative breast cancer that had low levels of Ki67 protein and a very low risk of recurrence were able to safely skip radiation after lumpectomy. Read more... -
After DCIS, About One in Five Invasive Breast Cancers Unrelated to Original DCIS
June 15, 2022
In the years following a DCIS (ductal carcinoma in situ) diagnosis, about one in five invasive breast cancers that developed were not related to the original DCIS lesion. Read more... -
Black and Hispanic Women May Have Higher Risk of Lymphedema
June 15, 2022
Among women who had breast cancer surgery and axillary lymph node dissection, Black and Hispanic women were more likely to develop lymphedema than white women, as were women who received chemotherapy before surgery, rather than after surgery. Read more... -
3D Mammograms Reduce Risk of Advanced-Stage Disease in Women With Extremely Dense Breasts and High Risk of Breast Cancer
June 15, 2022
In women with extremely dense breasts and a high risk of breast cancer, screening with 3D mammograms — rather than 2D digital mammograms — was linked to a lower risk of advanced-stage disease. Read more... -
Hormone-Free Medicine for Hot Flashes Shows Promise
June 21, 2022
Fezolinetant, an experimental medicine that doesn't contain hormones, has successfully treated hot flashes. Read more... -
Risk of Heart Problems Lower in Breast Cancer Survivors Who Exercise
Jun 27, 2022
Exercise helped reduce the risk of heart problems in women receiving treatment for breast cancer. Read more... -
Black Women Most Likely To Experience Biopsy Delays After Abnormal Mammogram
July 7, 2022
Women from various racial and ethnic backgrounds, particularly Black women, had a higher risk of biopsy delays after an abnormal mammogram than white women. Read more... -
Cancer Survivors Have Higher Risk of Cardiovascular Disease
July 11, 2022
Cancer survivors have a higher risk of developing cardiovascular disease, including heart failure and stroke, than people with no history of cancer. Read more... -
Giving Birth After Breast Cancer Doesn't Affect Survival
July 11, 2022
Having a baby after completing treatment for early-stage breast cancer doesn't negatively affect overall survival. Read more... -
Cases of Breast Implant-Related Cancer May Be More Than Double FDA Estimates
July 25, 2022
The number of U.S. cases of breast anaplastic large-cell lymphoma — a rare cancer linked to textured implants — may be twice as high as U.S. Food and Drug Administration estimates. Read more... -
HRT Doesn't Seem To Raise Risk of Breast Cancer Recurrence in Certain Women
July 28, 2022
Overall, neither systemic nor vaginal hormone replacement therapy (HRT) seemed to increase the risk of breast cancer recurrence (the cancer coming back) in women diagnosed with early-stage, estrogen receptor-positive disease. Still, using vaginal HRT slightly increased recurrence risk in women who received an aromatase inhibitor. Read more... -
Hearing Problems Common After Chemotherapy Treatment
July 28, 2022
Hearing loss and other hearing problems seem to be common in adults who've received chemotherapy for the four most common types of cancer, including breast cancer. Read more... -
Experimental Immunotherapy Medicine Works Similarly in Black and White Women With Triple-Negative Breast Cancer
Aug 4, 2022
When more Black women diagnosed with early-stage, triple-negative breast cancer joined a study on Imfinzi, the results showed the immunotherapy was as effective in Black women as it was in women of other races and ethnicities. Read more... -
Oral Paclitaxel Plus Encequidar Offers Better Response Than IV Paclitaxel in Metastatic Breast Cancer
Aug 4, 2022
Metastatic breast cancer responded better to a combination of the chemotherapy medicine paclitaxel in pill form and encequidar (a medicine that allows oral paclitaxel to be absorbed into the bloodstream) than to intravenous paclitaxel. Read more... -
FDA Approves Enhertu for Unresectable or Metastatic HER2-Low Breast Cancer
Aug 5, 2022
On Aug. 5, 2022, the U.S. Food and Drug Administration approved Enhertu to treat unresectable or metastatic HER2-low breast cancer. Read more... -
Knowing Moms' Hereditary Cancer Risk Doesn't Affect Kids' Quality of Life
Aug 8, 2022
Telling children that their mothers have a genetic risk of developing breast and ovarian cancer doesn't affect their long-term quality of life. Read more... -
Understanding How Mindfulness Meditation Reduces Pain
Aug 12, 2022
Mindfulness meditation seems to ease pain by allowing people to separate pain from things they're experiencing. Read more... -
Boost Dose After Radiation for Moderate- or High-Grade DCIS Reduces Recurrence Risk
Aug 15, 2022
After whole-breast radiation, a boost dose to the area where the tumor was further reduced the risk of moderate- or high-grade DCIS coming back. Read more... -
Piqray Linked to Colitis
August 22, 2022
Colitis has been identified as a new side effect of the targeted therapy Piqray. Read more... -
After Chemotherapy, Fatigue May Contribute More to Balance Problems Than Neuropathy
Aug 25, 2022
After receiving chemotherapy for breast cancer, women who had more severe, persistent fatigue were more likely to have balance problems, whether they had peripheral neuropathy or not. Read more... -
New NCCN Breast Cancer Screening Guidelines: Annual Mammograms Should Start at 40
Sep 7, 2022
Aiming to clarify when women should start having mammograms, the National Comprehensive Cancer Network has released new guidelines for breast cancer screening and diagnosis that say all women age 40 and older at average risk of breast cancer should have annual mammograms. Read more... -
Neurofeedback May Help Ease Chemo Brain
Sep 7, 2022
Neurofeedback — a type of therapy that uses a computer program to measure brain wave activity — shows promise for treating the mental fogginess many people have after chemotherapy. Read more... -
New CDK4/6 Inhibitor Offers Benefits for Advanced-Stage, Hormone Receptor-Positive, HER2-Negative Breast Cancer
Sep 13, 2022
When given as a first treatment, the combination of dalpiciclib — a new CDK4/6 inhibitor —with either Arimidex or Femara improved progression-free survival in women diagnosed with advanced-stage, hormone receptor-positive, HER2-negative breast cancer. Read more...
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team